IL164146A0 - - Google Patents
Info
- Publication number
- IL164146A0 IL164146A0 IL16414603A IL16414603A IL164146A0 IL 164146 A0 IL164146 A0 IL 164146A0 IL 16414603 A IL16414603 A IL 16414603A IL 16414603 A IL16414603 A IL 16414603A IL 164146 A0 IL164146 A0 IL 164146A0
- Authority
- IL
- Israel
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/86—Benzo [b] furans; Hydrogenated benzo [b] furans with an oxygen atom directly attached in position 7
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Immunology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Transplantation (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Furan Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AUPS1272A AUPS127202A0 (en) | 2002-03-20 | 2002-03-20 | Therapeutic ion channel blocking agents and methods of use thereof |
| PCT/AU2003/000351 WO2003078416A1 (en) | 2002-03-20 | 2003-03-20 | Therapeutic ion channel blocking agents and methods of use thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL164146A0 true IL164146A0 (xx) | 2005-12-18 |
Family
ID=3834869
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL16414603A IL164146A0 (xx) | 2002-03-20 | 2003-03-20 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US7507839B2 (xx) |
| EP (1) | EP1490349A4 (xx) |
| JP (1) | JP2005525384A (xx) |
| CN (1) | CN1656087A (xx) |
| AU (1) | AUPS127202A0 (xx) |
| CA (1) | CA2479481A1 (xx) |
| IL (1) | IL164146A0 (xx) |
| WO (1) | WO2003078416A1 (xx) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101006177B (zh) | 2002-03-15 | 2011-10-12 | 纽韦卢森公司 | 改善的用于合成模制分子的方法 |
| AR054181A1 (es) * | 2004-08-26 | 2007-06-06 | Nicholas Piramal India Ltd | Prodrogas que contienen enlaces bio-divisibles. composiiciones farmaceuticas |
| US8063093B2 (en) | 2005-03-15 | 2011-11-22 | Andrew J Harvey | Potassium channel blockers and uses thereof |
| WO2007139771A1 (en) * | 2006-05-22 | 2007-12-06 | The Johns Hopkins University | Kv channels in neurodegeneration and neuroprotection |
| WO2008040057A1 (en) * | 2006-10-04 | 2008-04-10 | Bionomics Limited | Novel benzofuran potassium channel blockers and uses thereof |
| BRPI0817520A2 (pt) * | 2007-10-04 | 2015-08-18 | Bionomics Ltd | Novos bloqueadores de canal de aril potássio e usos destes |
| TWI701249B (zh) | 2015-03-13 | 2020-08-11 | 德商４Ｓｃ製藥公司 | Ｋv１.３抑制劑及其醫學應用 |
| TWI698438B (zh) | 2015-03-13 | 2020-07-11 | 德商４Ｓｃ製藥公司 | Ｋv１.３抑制劑及其醫學應用 |
| CN106518995B (zh) * | 2016-11-08 | 2020-07-17 | 南方医科大学 | 印鼠客蚤多肽及其基因和应用 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE787838R (fr) | 1971-08-25 | 1973-02-22 | Delalande Sa | Nouveaux derives du cinnamoyl-5 benzofuranne, leur procede de preparation et leur utilisation en therapeutique |
| US4753965A (en) | 1987-04-09 | 1988-06-28 | Merrell Dow Pharmaceuticals, Inc. | Method of treating multiple sclerosis with chalcone derivatives |
| DE3727736A1 (de) * | 1987-08-20 | 1989-03-02 | Basf Ag | Neue benzofuranderivate und diese enthaltende therapeutische mittel |
| US5494895A (en) | 1993-07-22 | 1996-02-27 | Merck & Co., Inc. | Scorpion peptide margatoxin with immunosuppressant activity |
| CA2236171A1 (en) | 1995-10-31 | 1997-05-09 | Merck & Co., Inc. | Triterpene derivatives with immunosuppressant activity |
| EP0858456A4 (en) | 1995-10-31 | 1998-12-30 | Merck & Co Inc | TRITERPEN DERIVATIVES WITH IMMUNOSUPPRESSIVE ACTIVITY |
| AU5369798A (en) | 1996-11-27 | 1998-06-22 | Bachem Bioscience, Inc. | Shk toxin compositions and methods of use |
| US6362371B1 (en) * | 1998-06-08 | 2002-03-26 | Advanced Medicine, Inc. | β2- adrenergic receptor agonists |
| US6051590A (en) | 1999-05-13 | 2000-04-18 | Merck & Co., Inc. | Immunosuppressant tricyclic compounds |
-
2002
- 2002-03-20 AU AUPS1272A patent/AUPS127202A0/en not_active Abandoned
-
2003
- 2003-03-20 US US10/507,925 patent/US7507839B2/en not_active Expired - Fee Related
- 2003-03-20 JP JP2003576422A patent/JP2005525384A/ja active Pending
- 2003-03-20 WO PCT/AU2003/000351 patent/WO2003078416A1/en not_active Application Discontinuation
- 2003-03-20 EP EP03707912A patent/EP1490349A4/en not_active Withdrawn
- 2003-03-20 CN CNA038115050A patent/CN1656087A/zh active Pending
- 2003-03-20 IL IL16414603A patent/IL164146A0/xx unknown
- 2003-03-20 CA CA002479481A patent/CA2479481A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US20050261301A1 (en) | 2005-11-24 |
| US7507839B2 (en) | 2009-03-24 |
| CN1656087A (zh) | 2005-08-17 |
| EP1490349A1 (en) | 2004-12-29 |
| JP2005525384A (ja) | 2005-08-25 |
| AUPS127202A0 (en) | 2002-04-18 |
| WO2003078416A1 (en) | 2003-09-25 |
| EP1490349A4 (en) | 2006-01-04 |
| CA2479481A1 (en) | 2003-09-25 |